natgillin/translations-raw huggingface dataset:
Erythema and neurological signs (convulsions, ataxia and muscle tremors) have been reported very rarely. 
Vrlo rijetko su prijavljeni eritemi i neurološki znakovi (konvulzije, ataksija i mišićni tremor).
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. 
Buhe i krpelji moraju se prihvatiti na domaćina i započeti hranjenje kako bi bili izloženi aktivnoj tvari.
Afoxolaner acts as an antagonist at ligand-gated chloride channels, in particular those gated by the neurotransmitter gamma-aminobutyric acid (GABA). 
Afoksolaner djeluje kao antagonist na ligandom regulirane kloridne kanale, osobito one kojim upravlja neurotransmiter gama-aminomaslačna kiselina (GABA).
Monthly administration of the product until two negative skin scrapings are obtained one month apart. 
Mjesečna primjena proizvoda sve do pojave dva negativna nalaza dobivena pretragom strugotina kože uzetih u razmaku od mjesec dana.
Ask your veterinarian how to continue flea and tick treatment. 
Pitajte svojeg veterinara o nastavku liječenja invazije buha i krpelja.
1 chewable tablet 3 chewable tablets 6 chewable tablets 15 chewable tablets 
1 tableta za žvakanje 3 tablete za žvakanje 6 tableta za žvakanje 15 tableta za žvakanje
One carton contains one blister of 1, 3 or 6 chewable tablets or 15 blisters of 1 chewable tablet. 
Jedna kartonska kutija sadrži blister s 1, 3, ili 6 tableta za žvakanje ili 15 blistera s 1 tabletom za žvakanje.
The selective toxicity of afoxolaner between insects, acarines and mammals may be inferred by the differential sensitivity of the insects and acarines' GABA receptors versus mammalian GABA receptors. 
Selektivna toksičnost afoksolanera za insekte, akaride i sisavce se može zaključiti po različitoj osjetljivosti GABA receptora insekata/akarida u odnosu na receptore sisavaca.
Prevention of angiostrongylosis: 
Sprečavanje angiostrongiloze:
Milbemycin oxime distributes into tissues with a volume of distribution of 2.7 ± 0.4 l/kg and 2.6 ± 0.6 l/kg for the A3 and A4 forms, respectively. 
Milbemicin oksim se distribuira u tkiva s volumenom raspodjele koji iznosi 2,7 ± 0,4 l/kg i 2,6 ± 0,6 l/kg za A3 i A4 oblik.
- Keep tablets in the blister packs until required, and keep the blisters in the outer carton. 
- Držite tablete u blisteru do trenutka primjene i čuvajte blistere u pripadajućoj kartonskoj kutijici.
Macrogol 15 hydroxystearate Glycerol (E422) Triglycerides, medium-chain Citric acid monohydrate (E330) Butylhydroxytoluene (E321) 
Trigliceridi srednjeg lanca Limunska kiselina monohidrat (E330) Butil-hidroksitoluen (E321)
The recommended dose should be strictly observed in collies or related breeds. 
Preporučena doza se posebno striktno treba poštivati kod kolija i jedinki srodnih pasminama kolija.
Keep the blister in the outer carton in order to protect from light. 
Čuvajte blister u kartonskoj kutiji kako bi ga zaštitili od sunčevog svijetla.
Heartworm disease prevention is critical. 
Prevencija bolesti srčanog crva je od izuzetne važnosti.
Dogs living in heartworm endemic areas (where heartworm disease is present), or those which have travelled to endemic areas, may be infested with adult heartworms. 
Psi koji žive u područjima koja su endemična za bolest srčanog crva (gdje je bolest srčanog crva prisutna), ili oni koji su boravili u endemičnim područjima mogu imati ovog parazita.
No therapeutic effect against adult Dirofilaria immitis has been established. 
Ne postoji terapijski učinak ovog proizvoda na adulte crva Dirofilaria immitis.
Isoxazolines, among the chloride channel modulators, bind to a distinct and unique target site within the insect GABACls, thereby blocking pre- and post-synaptic transfer of chloride ions across cell membranes. 
Izoksazolini se kao modulatori kloridnih kanala vežu na određene jedinstvene GABA receptore insekta čime blokiraju pre i post-sinaptički prijenos kloridnih iona kroz stanične membrane.
Treatment of flea and tick infestations and gastrointestinal nematodes: 
Liječenje invazije buha, krpelja i gastrointestinalnih nematoda:
Treatment of flea infestations (Ctenocephalides felis and C. canis) in dogs for 5 weeks. 
Liječenje invazije buha (Ctenocephalides felis i C. canis) u pasa tijekom 5 tjedana.
Treatment of demodicosis (caused by Demodex canis): 
Liječenje demodikoze (uzrokovane s Demodex canis)
Treatment of flea infestations (Ctenocephalides felis and C. canis) in dogs. 
Liječenje invazije buha (Ctenocephalides felis i C. canis) u pasa.
Vomiting, diarrhoea, lack of energy, decreased appetite and itching were uncommonly observed. 
Kliničke studije Povraćanje, proljev, gubitak energije, smanjen apetit i svrab nisu često zamijećeni.
Treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis). 
Liječenje Sarcoptes-šuge (uzrokovane sa Sarcoptes scabiei var.canis).
It is therefore recommended that all dogs 8 months of age or more, living in heartworm endemic areas, should be tested for existing adult heartworm infestation before being treated with the product for heartworm prevention. 
Stoga se preporuča da se svi psi stari 8 mjeseci i više koji žive u endemičnim područjima bolesti srčanog crva testiraju na postojanje invazije adultima srčanog crva prije aplikacije proizvoda u prevenciji invazije ovog parazita.
NEXGARD SPECTRA is not indicated for microfilariae clearance. 
SPECTRA se ne koristi za uklanjanje mikrofilarija.
Milbemycin oxime plasma concentrations peak quickly within the first 1-2 hours (Tmax) indicating that absorption from the chewable tablets is fast. 
Koncentracija u plazmi milbemicin oksima brzo dolazi do vršne vrijednosti unutar prva 1-2 sata (Tmax)
Afoxolaner distributes into tissues with a volume of distribution of 2.6 ± 0.6 l/kg and a systemic clearance value of 5.0 ± 1.2 ml/h/kg. 
Afoksolaner se distribuira u tkiva s volumenom raspodjele koji iznosi 2,6 ± 0,6 l/kg te sustavnim klirensom vrijednosti 5,0 ± 1,2 ml/h/kg.
Laboratory studies in rats and rabbits have not produced any evidence of birth defects, or any adverse effect on the reproductive capacity in males and females. 
Laboratorijski pokusi na štakorima i kunićima nisu dali dokaz da proizvod može izazivati pojavu urođenih mana, ili bilo kakvog nepovoljnog učinka na reproduktivnu sposobnost mužjaka i ženki.
Special precautions to be taken by the person administering the veterinary medicinal product to animals 
Posebne mjere opreza koje mora poduzeti osoba koja primjenjuje veterinarsko-medicinski proizvod na životinjama:
Efficacy of the treatment against flea and tick infestations lasts for one month. 
Proizvod je učinkovit u liječenju invazije buha i krpelja u trajanju od jednog mjeseca nakon primjene.
A single treatment is effective for gastrointestinal worms. 
Jedna primjena proizvoda učinkovita je u liječenju invazije gastrointestinalnih crva.
Fleas and ticks need to start feeding on the host to become exposed to afoxolaner; therefore the risk of the transmission of vector-borne diseases cannot be excluded. 
Buhe i krpelji moraju započeti hranjenje na domaćinu da budu izloženi djelovanju afoksolanera, stoga se rizik od prijenosa bolesti koje prenose vektori ne može u potpunosti isključiti.
Vomiting, diarrhoea, lethargy, anorexia, and pruritus were uncommonly observed. 
Povraćanje, proljev, letargija, anoreksija i pruritus nisu često zamijećeni.
At the discretion of the veterinarian, infested dogs should be treated with an adulticide to remove adult heartworms. 
Prema procjeni veterinara, psi koji imaju invaziju srčanog crva trebaju se liječiti adulticidom kako bi se odrasle jedinke uklonile.
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports). 
- rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja) - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
Fleas and ticks need to start feeding on the host to become exposed to the substance afoxolaner; therefore the risk of the transmission of diseases by fleas and ticks cannot be excluded. 
Buhe i krpelji moraju započeti hranjenje na domaćinu da budu izloženi djelovanju djelatne tvari afoksolanera, stoga se rizik od prijenosa bolesti koje prenose buhe i krpelji ne može u potpunosti isključiti.
Each chewable tablet contains 9.375 mg afoxolaner and 1.875 mg milbemycin oxime Each chewable tablet contains 18.75 mg afoxolaner and 3.75 mg milbemycin oxime Each chewable tablet contains 37.5 mg afoxolaner and 7.5 mg milbemycin oxime Each chewable tablet contains 75 mg afoxolaner and 15 mg milbemycin oxime Each chewable tablet contains 150 mg afoxolaner and 30 mg milbemycin oxime 
Svaka žvakaća tableta sadrži 9,375 mg afoxolaner i 1,875 mg milbemycin oxime Svaka žvakaća tableta sadrži 18,75 mg afoxolaner i 3,75 mg milbemycin oxime Svaka žvakaća tableta sadrži 37,5 mg afoxolaner i 7,5 mg milbemycin oxime Svaka žvakaća tableta sadrži 75 mg afoxolaner i 15 mg milbemycin oxime Svaka žvakaća tableta sadrži 150 mg afoxolaner i 30 mg milbemycin oxime
When replacing another heartworm preventative product in a heartworm prevention programme, the first treatment with NEXGARD SPECTRA should start on the date when the former medication was due to have been administered. 
U slučaju da se umjesto nekog drugog proizvoda za prevenciju bolesti srčanog crva počne koristiti NEXGARD SPECTRA, prva aplikacija treba uslijediti na datum kada bi trebalo primijeniti prijašnji proizvod.
Prevention of thelaziosis: 
Prevencija telazioze:
In regions where heartworm disease is present, dogs should be tested for existing heartworm infestation prior to administration of NEXGARD SPECTRA. 
U područjima gdje je bolest srčanog crva prisutna pse treba testirati na postojanje invazije srčanim crvom prije nego što se NEXGARD SPECTRA primjeni.
NEXGARD SPECTRA can be used as part of the seasonal treatment of fleas and ticks (replacing treatment with a monovalent flea and tick product) in dogs with diagnosed concurrent gastrointestinal nematode infestations. 
NEXGARD SPECTRA može se koristiti kao dio sezonskog programa liječenja invazije buha i krpelja (umjesto liječenja proizvodom za zaštitu isključivo od buha i krpelja) u pasa koji istovremeno imaju dijagnosticiranu invaziju gastrointestinalnih nematoda.
Prevention of heartworm disease: 
Prevencija bolesti srčanog crva:
Treatment of tick infestations (Dermacentor reticulatus, Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus) in dogs for 4 weeks. 
Liječenje invazije krpelja (Dermacentor reticulatus, Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus) u pasa tijekom 4 tjedana.
NEXGARD SPECTRA can be used as part of the seasonal treatment of fleas and ticks (replacing a product authorised for the treatment of fleas/ticks only) in dogs with diagnosed concurrent gastrointestinal worm infestations. 
NEXGARD SPECTRA može se koristiti kao dio sezonskog programa liječenja invazije buha i krpelja (umjesto proizvoda za liječenje invazije isključivo buha ili krpelja) u pasa koji istovremeno imaju dijagnosticiranu invaziju gastrointestinalnih crva.
Dogs living in heartworm endemic areas, or those which have travelled to endemic areas, may be infested with adult heartworms. 
Psi koji žive u područjima koja su endemična za bolest srčanog crva ili oni koji su boravili u endemičnim područjima mogu imati ovog parazita.
Prevention of heartworm disease (Dirofilaria immitis larvae) with monthly administration. 
Prevencija bolesti srčanog crva (Dirofilaria immitis larve), mjesečnom primjenom.
Dogs 2-3.5 kg Dogs >3.5-7.5 kg Dogs >7.5-15 kg Dogs >15-30 kg Dogs >30-60 kg 
Psi 2-3,5 kg Psi >3,5-7,5 kg Psi >7,5-15 kg Psi >15-30 kg Psi >30-60 kg
Ancylostoma ceylanicum is reported as being endemic only in Southeast Asia, China, India, Japan, some Pacific islands, Australia, the Arab Peninsula, South Africa and South America. 
Ancylostoma ceylanicum je prijavljena kao endemična pojava samo u jugoistočnoj Aziji, Kini, Indiji,
The systemic absorption of afoxolaner is high. 
Afoksolaner ima visoku sustavnu apsorpciju.
In heartworm endemic areas, dogs should be tested for existing heartworm infestation prior to administration of NEXGARD SPECTRA. 
U endemičnim područjima za bolest srčanog crva pse treba testirati na postojanje invazije srčanim crvom prije nego što se NEXGARD SPECTRA primjeni.
Milbemycin oxime increases glutamate binding with consequent enhanced chloride ion flow into the cell. 
Povećava vezanje glutamata sa posljedičnim povećanim protokom iona klorida u stanicu.
Post-marketing safety experience 
Iskustva nakon puštanja lijeka u promet
Prevention of establishment of thelaziosis (adult Thelazia callipaeda eyeworm infection) with monthly administration. 
Prevencija nastanka telazioze (odrasli oblik Thelazia callipaeda, infestacija očnim crvom), mjesečnom primjenom.
It is active against adult fleas as well as against several tick species such as Rhipicephalus sanguineus, Dermacentor reticulatus and D. variabilis, Ixodes ricinus, Ixodes hexagonus and I. scapularis, Amblyomma americanum and Haemaphysalis longicornis. 
Djeluje protiv odraslih buha te protiv nekoliko vrsta krpelja poput Rhipicephalus sanguineus, Dermacentor reticulatus i D. variabilis, Ixodes ricinus, Ixodes hexagonus i I. scapularis, Amblyomma americanum i Haemaphysalis longicornis.
Mottled red to reddish brown, circular shaped (tablets for dogs 2-3.5 kg) or rectangular shaped (tablets for dogs >3.5-7.5 kg, tablets for dogs >7.5-15 kg, tablets for dogs >15-30 kg and tablets for dogs >30-60 kg). 
Išarane crvenkaste do crvenkasto smeđe, kružnog (tablete za pse 2-3,5 kg) ili pravokutnog oblika (tablete za pse >3,5-7,5 kg, tablete za pse >7,5-15 kg, tablete za pse >15-30 kg i tablete za pse >30-60 kg).
It is active against adult fleas as well as against several tick species such as Rhipicephalus sanguineus, Dermacentor reticulatus and D. variabilis, Ixodes ricinus and I. scapularis, Amblyomma americanum, and Haemaphysalis longicornis. 
Afoksolaner djeluje protiv odraslih buha te protiv nekoliko vrsta krpelja poput Rhipicephalus sanguineus, Dermacentor reticulatus i D. variabilis, Ixodes ricinus i I. scapularis, Amblyomma americanum i Haemaphysalis longicornis.
Prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum) with monthly administration. 
Sprečavanje angiostrongiloze (zahvaljujući smanjenju razine invazije s nezrelim odraslim oblicima (L5) i odraslim crvima Angiostrongylus vasorum) kroz mjesečnu primjenu.
Milbemycin oxime acts by disrupting the glutamate neuro-transmission in invertebrates. 
Milbemicin oksim djeluje na način da ometa neurotransmisiju reguliranu glutamatima kod beskralježnjaka.
Monthly administration of the product prevents establishment of infection with adult Thelazia callipaeda eyeworm. 
Mjesečna primjena ovog veterinarsko-medicinskog proizvoda sprečava nastanak infestacije odraslim oblikom očnog crva Thelazia callipaeda.
Treatment of tick infestations (Dermacentor reticulatus, Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus) in dogs. 
Liječenje invazije krpelja (Dermacentor reticulatus, Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus) u pasa.
In endemic areas, monthly administration of the product will reduce the level of infection with immature adults (L5) and adults of Angiostrongylus vasorum in the heart and lungs. 
U endemičnim područjima mjesečna primjena ovog veterinarsko medicinskog proizvoda smanjit će razinu invazije srca i pluća nezrelim odraslim oblicima (L5) i odraslim crvima Angiostrongylus vasorum.
After treatment of the nematode infestations, further flea and tick treatment should be continued with a monovalent product. 
Jedna primjena proizvoda učinkovita je u liječenju invazije nematoda, daljnje liječenje invazije buha i krpelja treba se odraditi proizvodom za zaštitu od buha i krpelja.
For each strength, the chewable tablets are available in the following pack sizes: Carton with 1 thermoformed blister containing 1, 3 or 6 chewable tablets or 15 thermoformed blisters containing 1 chewable tablet. 
Kutija s 1 termoformiranim blisterom s 1, 3 ili 6 tableta za žvakanje ili 15 termoformiranih blistera s 1 tabletom za žvakanje.
Milbemycin oxime is active against several gastrointestinal worms (Toxocara canis, Toxascaris leonina, Ancylostoma caninum, Ancylostoma braziliense, Ancylostoma ceylanicum, Trichuris vulpis), the adults and immature adults (L5) of lungworm Angiostrongylus vasorum and heartworm (Dirofilaria immitis larvae). 
Milbemicin oksim djeluje protiv nekolicine gastrointestinalnih nematoda (Toxocara canis, Toxascaris leonina, Ancylostoma caninum, Ancylostoma braziliense, Ancylostoma ceylanicum, Trichuris vulpis), odraslih oblika i nezrelih odraslih oblika (L5) plućnog nematoda Angiostrongylus vasorum i srčanog crva (Dirofilaria immitis larve).
It is active against several gastrointestinal worms (Toxocara canis, Toxascaris leonina, Ancylostoma caninum, Ancylostoma braziliense, Ancylostoma ceylanicum, Trichuris vulpis), the adults and immature adults (L5) of lungworm Angiostrongylus vasorum and larvae of the heartworm Dirofilaria immitis. 
Djeluje protiv nekolicine gastrointestinalnih crva (Toxocara canis, Toxascaris leonina, Ancylostoma caninum, Ancylostoma braziliense, Ancylostoma ceylanicum, Trichuris vulpis) te protiv odraslih oblika i nezrelih odraslih oblika (L5) plućnog nematoda Angiostrongylus vasorum i larvi srčanog crva Dirofilaria immitis.
Treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (Toxocara canis and Toxascaris leonina), hookworms (Ancylostoma caninum, Ancylostoma braziliense and Ancylostoma ceylanicum) and whipworm (Trichuris vulpis). 
Liječenje invazije odraslih gastrointestinalnih nematoda sljedećih vrsta: oblići (Toxocara canis i Toxascaris leonina), kukičasti crvi (Ancylostoma caninum, Ancylostoma braziliense i Ancylostoma ceylanicum) i bičasti crv (Trichuris vulpis).
Manufacturer responsible for batch release: MERIAL, 
Proizvođač odgovoran za puštanje serije u promet:
Only negative animals should be treated. 
Samo negativnim jedinkama može se primijeniti ovaj veterinarsko-medicinski proizvod.
EU/2/14/177/007 - 38 mg/ 8 mg, 1 chewable tablet EU/2/14/177/008 - 38 mg/ 8 mg, 3 chewable tablets EU/2/14/177/009 - 38 mg/ 8 mg, 6 chewable tablets EU/2/14/177/018 - 38 mg/ 8 mg, 15 chewable tablets EU/2/14/177/010 - 75 mg/ 15 mg, 1 chewable tablet EU/2/14/177/011 - 75 mg/ 15 mg, 3 chewable tablets EU/2/14/177/012 - 75 mg/ 15 mg, 6 chewable tablets EU/2/14/177/019 - 75 mg/ 15 mg, 15 chewable tablets EU/2/14/177/013 -150 mg/ 30 mg, 1 chewable tablet EU/2/14/177/014 -150 mg/ 30 mg, 3 chewable tablets EU/2/14/177/015 -150 mg/ 30 mg, 6 chewable tablets EU/2/14/177/020 -150 mg/ 30 mg, 15 chewable tablets 
EU/2/14/177/001 - 9 mg/ 2 mg, 1 tableta za žvakanje EU/2/14/177/002 - 9 mg/ 2 mg, 3 tablete za žvakanje EU/2/14/177/003 - 9 mg/ 2 mg, 6 tableta za žvakanje EU/2/14/177/016 - 9 mg/ 2 mg, 15 tableta za žvakanje EU/2/14/177/004 - 19 mg/ 4 mg, 1 tableta za žvakanje EU/2/14/177/005 - 19 mg/ 4 mg, 3 tablete za žvakanje EU/2/14/177/006 - 19 mg/ 4 mg, 6 tableta za žvakanje EU/2/14/177/017 - 19 mg/ 4 mg, 15 tableta za žvakanje EU/2/14/177/007 - 38 mg/ 8 mg, 1 tableta za žvakanje EU/2/14/177/008 - 38 mg/ 8 mg, 3 tablete za žvakanje EU/2/14/177/009 - 38 mg/ 8 mg, 6 tableta za žvakanje EU/2/14/177/018 - 38 mg/ 8 mg, 15 tableta za žvakanje EU/2/14/177/010 - 75 mg/ 15 mg, 1 tableta za žvakanje EU/2/14/177/011 - 75 mg/ 15 mg, 3 tablete za žvakanje EU/2/14/177/012 - 75 mg/ 15 mg, 6 tableta za žvakanje EU/2/14/177/019 - 75 mg/ 15 mg, 15 tableta za žvakanje EU/2/14/177/013 -150 mg/ 30 mg, 1 tableta za žvakanje EU/2/14/177/014 -150 mg/ 30 mg, 3 tablete za žvakanje EU/2/14/177/015 -150 mg/ 30 mg, 6 tableta za žvakanje EU/2/14/177/020 -150 mg/ 30 mg, 15 tableta za žvakanje
Each chewable tablet contains the active substances: 
Svaka tableta za žvakanje sadrži djelatne tvari: NEXGARD SPECTRA
Ancylostoma ceylanicum is reported as being endemic only in South-East Asia, China, India, Japan, some Pacific islands, Australia, the Arab Peninsula, South Africa and South America. 
Japanu, nekim otocima u Tihom oceanu, Australiji, na Arapskom poluotoku te u Južnoj Africi i Južnoj Americi.
Name and address of the manufacturer(s) responsible for batch release 
PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE U PROMET Naziv i adresa proizvođača odgovornog<ih> za puštanje serije u promet
NEXGARD SPECTRA 9 mg/ 2 mg dogs 2-3.5 kg NEXGARD SPECTRA 19 mg/ 4 mg dogs >3.5-7.5 kg NEXGARD SPECTRA 38 mg/ 8 mg dogs >7.5-15 kg NEXGARD SPECTRA 75 mg/ 15 mg dogs >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg dogs >30-60 kg afoxolaner / milbemycin oxime Tablets 
NEXGARD SPECTRA 9 mg/ 2 mg psi 2-3,5 kg NEXGARD SPECTRA 19 mg/ 4 mg psi >3,5-7,5 kg NEXGARD SPECTRA 38 mg/ 8 mg psi >7,5-15 kg NEXGARD SPECTRA 75 mg/ 15 mg psi >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg psi >30-60 kg afoxolaner / milbemycin oxime Tablete
Treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis): 
Liječenje demodikoze (uzrokovane s Demodex canis) Liječenje Sarcoptes-šuge (uzrokovane sa Sarcoptes scabiei var. canis) Prevencija bolesti srčanog crva (Dirofilaria immitis larve) kroz mjesečnu primjenu.
NEXGARD SPECTRA 9 mg/ 2 mg chewable tablets for dogs 2-3.5 kg NEXGARD SPECTRA 19 mg/ 4 mg chewable tablets for dogs >3.5-7.5 kg NEXGARD SPECTRA 38 mg/ 8 mg chewable tablets for dogs >7.5-15 kg NEXGARD SPECTRA 75 mg/ 15 mg chewable tablets for dogs >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg chewable tablets for dogs >30-60 kg afoxolaner / milbemycin oxime 
NEXGARD SPECTRA 9 mg/ 2 mg tableta za žvakanje za pse 2-3,5 kg NEXGARD SPECTRA 19 mg/ 4 mg tableta za žvakanje za pse >3,5-7,5 kg NEXGARD SPECTRA 38 mg/ 8 mg tableta za žvakanje za pse >7,5-15 kg NEXGARD SPECTRA 75 mg/ 15 mg tableta za žvakanje za pse >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg tableta za žvakanje za pse >30-60 kg afoxolaner / milbemycin oxime
PACKAGE LEAFLET: NEXGARD SPECTRA 9 mg / 2 mg chewable tablets for dogs 2-3.5 kg NEXGARD SPECTRA 19 mg / 4 mg chewable tablets for dogs >3.5-7.5 kg NEXGARD SPECTRA 38 mg / 8 mg chewable tablets for dogs >7.5-15 kg NEXGARD SPECTRA 75 mg / 15 mg chewable tablets for dogs >15-30 kg NEXGARD SPECTRA 150 mg / 30 mg chewable tablets for dogs >30-60 kg 
UPUTA O VMP: NEXGARD SPECTRA 9 mg/ 2 mg tablete za žvakanje za pse 2-3,5 kg NEXGARD SPECTRA 19 mg/ 4 mg tablete za žvakanje za pse >3,5-7,5 kg NEXGARD SPECTRA 38 mg/ 8 mg tablete za žvakanje za pse >7,5-15 kg NEXGARD SPECTRA 75 mg/ 15 mg tablete za žvakanje za pse >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg tablete za žvakanje za pse >30-60 kg
NEXGARD SPECTRA 9 mg / 2 mg chewable tablets for dogs 2-3.5 kg NEXGARD SPECTRA 19 mg / 4 mg chewable tablets for dogs >3.5-7.5 kg NEXGARD SPECTRA 38 mg / 8 mg chewable tablets for dogs >7.5-15 kg NEXGARD SPECTRA 75 mg / 15 mg chewable tablets for dogs >15-30 kg NEXGARD SPECTRA 150 mg / 30 mg chewable tablets for dogs >30-60 kg 
NEXGARD SPECTRA 9 mg/ 2 mg tablete za žvakanje za pse 2-3,5 kg NEXGARD SPECTRA 19 mg/ 4 mg tablete za žvakanje za pse >3,5-7,5 kg NEXGARD SPECTRA 38 mg/ 8 mg tablete za žvakanje za pse >7,5-15 kg NEXGARD SPECTRA 75 mg/ 15 mg tablete za žvakanje za pse >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg tablete za žvakanje za pse >30-60 kg
It will be given to you once every 2 weeks. 
Primit ćete je jedanput svaka 2 tjedna.
ATC code: A16AB07. 
ATK oznaka: A16AB07.
OTHER SPECIAL WARNING(S), IF NECESSARY 
DRUGO(A) POSEBNA UPOZORENJE(A), AKO JE POTREBNO
The results are shown in Table 4. 
Rezultati su prikazani u Tablici 4.
The dose you receive is based on your body weight. 
Doza koju ćete primiti ovisi o Vašoj tjelesnoj težini.
Evaluation of motor function gave disparate results. 
Procjena motoričkih funkcija dala je različite rezultate.
However, motor and respiratory responses to treatment have been more variable. 
Međutim, motorički i respiratorni odgovori na liječenje bili su varijabilniji.